Industrially prefabricated cement spacers: Do vancomycin-and gentamicin-impregnated spacers offer any advantage?

Pablo S. Corona, Victor Barro, Marye Mendez, Enric Cáceres, Xavier Flores

    Research output: Contribution to journalArticleResearchpeer-review

    18 Citations (Scopus)

    Abstract

    Background: Industrially preformed antibiotic-loaded cement spacers are useful to facilitate the second stage of two-stage exchange arthroplasty for infected THAs and TKAs. However, whether gentamicin alone or a combination of antibiotics (such as vancomycin and gentamicin) is more effective is not known. Questions/purposes: We therefore sought to compare industrially prefabricated spacers containing either gentamicin or gentamicin and vancomycin with respect to (1) infection control, (2) complications, and (3) quality of life, pain, and patient satisfaction. Methods: We performed a review of 51 patients with chronic infections treated at one center using either gentamicin or vancomycin and gentamicin-prefabricated spacers. The former were used exclusively from January 2006 until May 2009, and the latter from June 2009 until July 2011, and there was no overlap. We collected data on demographics, immunologic status (McPherson classification), prosthetic joint infection location, type of prosthesis, microbiologic results, and time between stages. We evaluated the primary outcome of infection control or recurrence after at least 12 months followup. We also recorded complications. Each patient completed a quality-of-life survey, VAS, and a self-administered satisfaction scale. Results: The overall infection control rate was 83% after a mean followup of 35 months (range, 12.4-64.7 months). There were no differences between gentamicin and vancomycin and gentamicin spacers in terms of infection eradication (80% versus 85%, respectively; p = 0.73), nor in terms of complications, quality of life, pain, or satisfaction scores. Conclusions: Prefabricated, antibiotic-loaded cement spacers has been proven effective for infection control in TKAs and THAs but with the numbers available, we did not find any differences between a gentamicin or vancomycin and gentamicin-prefabricated spacer, and therefore, we are unable to validate the superiority of the combination of vancomycin and gentamicin over gentamicin alone. Because of the higher costs involved with vancomycin and gentamicin spacers, and the potential risks of unselective use of vancomycin, further comparative studies are necessary to evaluate their role in the treatment of infected THAs or TKAs. Level of Evidence: Level III, therapeutic study. See the Instructions for Authors for a complete description of levels of evidence. © The Association of Bone and Joint Surgeons1 2013.
    Original languageEnglish
    Pages (from-to)923-932
    JournalClinical Orthopaedics and Related Research
    Volume472
    Issue number3
    DOIs
    Publication statusPublished - 1 Jan 2014

    Fingerprint Dive into the research topics of 'Industrially prefabricated cement spacers: Do vancomycin-and gentamicin-impregnated spacers offer any advantage?'. Together they form a unique fingerprint.

    Cite this